First Pass

8 stories from 4 sources

Big buyers target scale across media, biotech and travel

Day’s Recap

Supporting Articles

Vertex will pay $10 billion to acquire Crinetics Pharmaceuticals, adding Crinetics' drug for a rare endocrine disorder to its portfolio. The deal extends a wave of large-cap biotech acquisitions aimed at buying late-stage or de-risked assets.

4:52 PMStat News

The July 4 weekend box office underperformed expectations, with Universal and Illumination’s “Minions and Monsters” posting a soft U.S. debut while Angel Studios’ indie “Young Washington” delivered a stronger-than-expected turnout. Comcast-owned Sky agreed to buy U.K. broadcaster ITV as it looks to scale up content and distribution in a tougher TV ad and streaming market.

8:44 PMVariety

Sky agreed a £1.6bn deal to acquire ITV, consolidating two major UK broadcasters. The combination would leave Comcast in control of a broadcaster reaching about 21 million households.

7:46 AMFinancial Times

EasyJet’s board said it has an outline agreement with Castlelake on a roughly £5 billion all cash takeover and is minded to recommend the deal. The proposal comes from the US private credit group after multiple prior approaches.

10:28 AMFinancial Times

EasyJet agreed in principle to a takeover offer worth more than £5 billion from Castlelake. The bid comes as the airline faces higher jet fuel costs and weaker demand following the Iran war.

1:56 AMBloomberg Markets

Other Developments

A curated list of other prominent stories from this day.

Vista Equity Partners and Quinti Capital have teamed up on a takeover offer for French ad-tech company Criteo, according to people familiar with the matter. The approach puts a potential privatization deal in play for a public ad-tech platform exposed to shifting digital ad measurement and retail media dynamics.

2:53 PMBloomberg Markets

Lockheed Martin agreed to acquire Ultra Maritime for $3.45 billion. Ultra Maritime makes naval defense systems focused on submarine detection, expanding Lockheed's undersea portfolio.

8:28 AMBloomberg Markets

Novartis agreed to acquire a UK cancer-focused biotech for $1.5bn. The target was formed in 2019 as a spinout from Imperial College and the Francis Crick Institute.

4:02 AMFinancial Times

Make it yours

Build Your First Pass.

Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!